This leads to increased EGFR protein expression (due to p38γ) and enhanced EGFR de-phosphorylation (due to PTPH1), resulting in a phenotype of increased levels of un-phosphorylated EGFR proteins in KRAS-mutant colon cancer cells [54]. This evidence concerns the gene KRAS and colonic neoplasm.